FIELD: pharmacology.
SUBSTANCE: new compounds are obtained that can be used to treat schizophrenia, obsessive-compulsive personality disorders, major depression, bipolar disorders, anxiety, normal aging, epilepsy, retinal degeneration, traumatic brain damage, spinal cord injuries, posttraumatic stress, panic disorders, Parkinson's disease , dementia, Alzheimer's disease, mild cognitive impairment, chemotherapy-induced cognitive dysfunction, Down's syndrome, diseases from the autism spectrum, and loss of hearing, ringing in the ears, spinal-cerebellar ataxia, amyotrophic lateral sclerosis, multiple sclerosis, Huntington's disease, stroke, radiation therapy, chronic stress, abuse of neuroactive substances such as alcohol, opiates, methamphetamine, phencyclidine and cocaine.
EFFECT: increased efficiency of treatment.
12 cl, 44 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF IMIDAZOPYRIDINE STIMULATING NEUROGENESIS | 2013 |
|
RU2644949C2 |
| PIPERAZINO[1,2-A]INDOLE-1-ONES AND [1,4] DIAZEPTINO[1,2-A]INDOLE-1-ONE | 2014 |
|
RU2628126C2 |
| BENZIMIDAZOLES AS CNS ACTIVE AGENTS | 2013 |
|
RU2647585C2 |
| 1,4 THIAZEPINES/SULPHONES AS BACE1 AND/OR BACE2 INHIBITORS | 2012 |
|
RU2600931C2 |
| PIPERIDINE DERIVATIVES | 2011 |
|
RU2554353C2 |
| DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS I mGluR2 ANTAGONISTS | 2002 |
|
RU2270197C2 |
| INDOLE-CARBOXAMIDE DERIVATIVES | 2014 |
|
RU2673489C2 |
| COMT INHIBITORS | 2013 |
|
RU2642779C2 |
| PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS | 2006 |
|
RU2411237C2 |
| NOVEL BENZODIOXOLS | 2003 |
|
RU2304580C2 |
